Explore educational content from VCCC lectures, symposia and conferences to be informed of the latest developments.
Wednesday 31 March 2021
Cancer and COVID-19 in Victoria moderated by A/Prof Sue-Anne McLachlan, VCCN Taskforce Chair and Director of Oncology and Cancer Services, St Vincent's Hospital, Melbourne,
An expert multidisciplinary panel discuss the latest COVID-19 vaccine safety and efficacy information, guidelines for vaccination for people with cancer and a patient’s lived experience of a COVID-19 diagnosis during cancer treatment, and the challenges of being on active cancer treatment during the pandemic.
Presenters: Prof Ben Cowie, Deputy Chief Health Officer, Department of Health, Dr Ben Teh, Infectious Diseases Physician, Peter MacCallum Cancer Centre, Prof Huyen Tran, Director of the Haemophilia Centre, Alfred Hospital, Dr Ines Rio, medical advisor and Chair, North Western Melbourne PHN and Donald Johnson, Nurse Unit Manager, Western Health COVID-19 Vaccine Hub.
Tuesday 30 March 2021
Head and Neck Cancer Symposium hosted by Professor David Wiesenfeld, VCCC Research & Education Lead for Head and Neck Cancer and Dr. Lachlan McDowell, Consultant Radiation Oncologist, Peter MacCallum Cancer Centre.
Multidisciplinary experts discuss the collective impact of a head and neck cancer diagnosis and how it may affect a patient's sense of self whilst addressing their sexual health post-survivorship.
Panel discussion with Professor Jane Hocking, Epidemiologist, University of Melbourne and Julie McCrossin AM, Consumer representative.
Monday 1 March 2021
Monday Lunch Live with Mr David Wrede, Royal Women's Hospital and Professor Marion Saville AM, VCS Foundation Ltd. Hosted by Tamara Oudyn, ABC News.
As a result of its world-leading screening and vaccination programs, Australia is well on track to eliminate cervical cancer by 2035. Yet even here we can't be complacent. The COVID-19 pandemic impacted screening rates as women put off their regular health checks.
Experts Mr David Wrede and Professor Marion Saville AM navigate the opportunities and challenges of the World Health Organisation's call for the global elimination of cervical cancer by 2100.
Wednesday 24 February 2021
Grand Round Breast Cancer with Professor Christobel Saunders AO, Professor of Surgical Oncology, University of Western Australia.
Internationally recognised cancer surgeon, Professor Christobel Saunders AO, presents her exciting new work seeking to improve the outcomes of breast tumour surgery.
The new technology and method aim to localise small impalpable tumours to distinguish if any tumour tissue, even microscopic amounts, have been left behind at surgery to ensure the best possible result.
Monday 22 February 2021
Monday Lunch Live with Associate Professor Gerry Hanna, Peter MacCallum Cancer Centre.
Whilst radiation therapy is still seen as core treatment and is known to elicit an immune response, combination therapy has been highly successful in a range of treatment settings.
However, there still is a lot of unknown regarding the interaction of the two treatments and how to avoid enhanced toxicity from their combinations. Associate Professor Hanna reviews the synergy between radiotherapy and immunotherapy research at Peter MacCallum Cancer Centre.
Friday 19 February 2021
VCCC Breast Cancer Symposium with Dr Ann Partridge, Dana-Farber Cancer Institute and Harvard Medical School.
What are the improvements in therapy and care for young women with breast cancer, and how can we apply these in Australia?
Dr Partridge explores the complexities of breast cancer in young women. Due to its rarity, treatment is often based on data from trials conducted among older women. This means that many aspects of the disease in younger women are not well understood and may result in long-term effects of treatment, and specific survivorship issues such as infertility.
Monday 15 February 2021
Monday Lunch Live with Dr Megan Prictor, Melbourne Law School and Amelia Hyatt, Department of Cancer Experiences Research, Peter MacCallum Cancer Centre.
Listening to a recording of a consultation with their health provider can help patients remember and understand what was discussed while giving them the opportunity to share information about a diagnosis or treatment regime with family members. New technologies to facilitate consultation recording are being developed globally - including the SECOND Ears smartphone app. This presentation explores the legal questions the SECOND Ears app has raised, and the results of a comprehensive analysis of Australian law pertaining to consultation recording.
Wednesday 10 February 2021
Grand Round Breast Cancer with Alastair Thompson, Baylor College of Medicine, Texas.
Professor Alastair Thompson, Baylor College of Medicine, Texas reviews the pathology, clinical management, and underlying mechanisms of ductal carcinoma in situ (DCIS) of the breast.
Professor Thompson is an international leader and specialist in breast cancer, his academic activities span translational laboratory research through clinical trials to implementation of improved practices for women and men with breast cancer.
Monday 8 February 2021
Monday Lunch Live with Professor Nick Huntington, Head of the Cancer Immunotherapy Laboratory, Biomedicine Discovery Institute, Monash University.
Emerging leader in the field of cancer immunology, Professor Huntington discusses how NK cells offer a safe cancer immunotherapy target and discuss therapeutic strategies to harness NK cell activity that is being developed at a rapid rate.
Thursday 4 February 2021
World Cancer Day with Dr Belinda Lee, Dr Stephen Luen and Dr Richard Tothill and consumer representative Vicky Morrison.
This special World Cancer Day event builds awareness of genetic testing and its impacts on cancer care. Our panel explores the opportunities that occur when patients, researchers and clinicians work together in a truly multidisciplinary way - and how this can progress cancer care universally.
Tuesday 1 December 2020
RACGP and VCCC event with presenters Professor Jon Emery, VCCC Primary Care Research and Education Lead, Professor Linda Mileshkin, Medical Oncologist and Deputy Director of Medical Oncology, Peter MacCallum Cancer Centre, Associate Professor Orla McNally Gynaecological Oncologist and Director of Oncology, Gynaecology, Royal Women’s Hospital.
Experts discuss the significant role General Practitioners play in gynaecological cancer prevention, screening, follow-up after treatment and palliative care and the scope to expand the role in collaboration with cancer specialists.
Monday 23 November 2020
Monday Lunch Live with presenter Associate Professor Lesley Stafford, Clinical Psychologist and Head of Clinical Psychology at The Royal Women’s Hospital and host Kirsten Pilatti, CEO, Breast Cancer Network Australia.
Professor Stafford discusses the mental health signs to watch for during and after a breast cancer diagnosis identifying when and how depression and anxiety can impact on day-to-day lives, and how to navigate the health system to find key professionals and support networks who can help.
Monday 30 November 2020
Monday Lunch Live with presenter Professor Christobel Saunders AO and Professor Nancy Baxter, Head of the Melbourne School of Population of Population and Global Health, The University of Melbourne.
Internationally recognised cancer expert Professor Christobel Saunders AO discusses the value-based system approach to service, delivery, payment, and policy to improve the lives of those diagnosed with cancer. She explains what value-based healthcare is, how to measure variability in outcomes and how to organise cancer care in a value-based model.
Monday 7 December 2020
Monday Lunch Live with Jon Yeo, Executive Coach, Board Member of Professional Speakers Australia and licensee of TEDx Melbourne.
Today, science communication has a real challenge to separate itself from noise and fake news. If real science is to make its mark, we need to understand modern communication practice that is clear, concise and builds trust. How does science need to be responsible and responsive to the community especially in the post-COVID-19 era?
In this interactive webinar, Jon works with participants to develop a short and effective narrative, and shares tips on creating memorable "sound bites" and moments, creating trust and rapport with your audience and cutting through 'fake-news'.
Monday 9 November 2020
Monday Lunch Live with presenter Professor Ben Solomon, Peter MacCallum Cancer Centre and A/Professor Gavin Wright
Lung cancers account for more cancer related deaths than any cancer worldwide. About 3 to 5% of patients with non-small cell lung cancer have tumours with rearrangements in the anaplastic lymphoma kinase gene.
Professor Solomon discusses the phase I to III clinical trials that are dramatically improving outcomes for patients with advanced lung cancer.
Thursday 5 November 2020
RACGP and VCCC event with presenter Professor Jon Emery, VCCC Primary Care Research and Education Lead.
An expert panel share commonplace experiences in the head and neck cancer pathway - from diagnosis, presenting symptoms to management principles and follow-up care with tips on best practice care, key communication points and challenges GPs face.
Wednesday 4 November 2020
Grand Round Breast Cancer with presenter Dr Shom Goel, Clinician-Scientist, Peter MacCallum Cancer Centre.
CDK4/6 inhibitors are a new class of drugs that have revolutionised the treatment of breast cancer. In this webinar, Dr Shom Goel reviews the rationale behind the development of CDK4/6 inhibitors and discusses recent laboratory data suggesting that their effects in cancer are much more complicated than previously imagined.
Friday 6 November 2020
Cancer and COVID-19 in Victoria with presenter Dr Ziad Bakouny.
Globally, people with cancer are one of the largest groups to be impacted by COVID-19. In addition to the physical impact on patients, the delivery of cancer care and research has been severely disrupted.
Dr Ziad Bakouny, Dana-Farber Cancer Institute, Boston USA, highlights the biological interplay between the two diseases and provides practical recommendations for the treatment of patients with cancer during the pandemic.
Ziad Bakouny, MD, MSc is a post-doctoral research fellow at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute (DFCI).
Monday 26 October 2020
Monday Lunch Live with presenter Dr Jennifer McQuade, MD Anderson Cancer Centre
Immunotherapy has dramatically changed the landscape of cancer care, with numerous immunotherapeutic strategies now being implemented across the therapeutic continuum. However, despite this tremendous success, a significant proportion of patients still do not fully benefit from these therapies. Thankfully the microbiome—and the foods that feed it—is emerging as an important determinant of a patient’s response to immunotherapy, with promising outcomes.
Dr Jennifer McQuade, MD Anderson Cancer Centre reviews the gut microbiome and explains how it is an important emerging biomarker to be considered in the response to revolutionary new cancer therapies.
Wednesday 21 October 2020
Cancer and COVID-19 with presenter Professor Jon Emery, VCCC Primary Care Research and Education Lead.
COVID-19 restrictions in Victoria has led to a reduction in pathology notifications for cancer of approximately 30 per cent for the five most common cancers. These cancers represent 60 per cent of all cancer diagnoses. This webinar aims to provide support and advice to clinicians and health care services treating patients with cancer during the COVID-19 pandemic.
Leading experts discuss the role of primary care professionals in addressing community concerns during COVID-19, identifying and responding to patients presenting with a late diagnosis cancer and the consequences of delayed cancer diagnoses on the health system.
Monday 19 October 2020
Monday Lunch Live with presenters Professor Joe Trapani and Associate Professor Paul Neeson. Moderated by Professor Sharon Lewin AO.
In the past decade, adoptive immunotherapies in the form of recombinant checkpoint antibodies or chimeric antigen receptor CAR T-cells have realised a century-long quest to harness the immune system to control established cancer.
Professor Trapani, Head Cancer Immunology Program, Peter MacCallum Cancer Centre reflects on the history of CAR T-cell technology and explores strategies currently being developed to extend the range of cancers for which CAR T and related approaches can prove effective. Joined by Associate Professor Paul Neeson, Group Leader, Cancer Immunology Program and moderated by Professor Sharon Lewin AO, Director, The Peter Doherty Institute for Infection and Immunity.
Monday 12 October 2020
Monday Lunch Live with presenter Dr Orazio Vittorio
Blocking copper uptake in tumour cells may be a clue to boosting immune system - fighting the deadliest of cancers.
Dr Vittorio, Head of The Metal-Targeted Therapy and Immunology Lab at the Children's Cancer Institute NSW has identified a strong connection between copper transporters found in malignant cancer tissue compared with normal tissue (copper transporter 1 CTR-1 and PD-L1). He presents cutting-edge research that proves that chelation therapy enhances anti-tumour immune responses and could be repurposed for immune checkpoint inhibition.
Friday 9 October 2020
Cancer and COVID-19 in Victoria with Professor Jennifer Philip, Danielle Spence, Associate Professor Brian Le, Associate Professor Mark Boughey, Dr Michelle Gold, Gael Wilder and Dan Fleming
For people requiring care due to a life-limiting illness, and the healthcare workers who care for them, COVID-19 presents particularly complex physical, emotional and ethical challenges.
In this webinar a multidisciplinary panel explores the clinical, ethical and patient experience including challenges to service delivery, bridging the ethical priorities and compassionate care and the impact on patients and families.
Monday 5 October 2020
Monday Lunch Live with presenter Associate Professor Misty Jenkins
In this webinar Misty discusses her research into how CAR T-cell immunotherapy is providing an exciting new approach to enhance brain cancer survival rates.
The presentation covers the generation and testing of two novel chimeric antigen receptor T cells. The first targets EGFRvIII, which serves as an attractive therapeutic target for glioblastoma given its exquisitely tumour specific expression.
Monday 29 September 2020
Monday Lunch Live with Associate Professor Fiona Simpson
Associate Professor Fiona Simpson is a Fellow of the Queensland Head and Neck Cancer Centre. Her lab focuses on the translation of research findings into new cancer therapies and have recently generated an exciting new method for antibody-mediated cancer therapy. This breakthrough method reduces tumour target variation, reversing drug resistance and increasing drug targeting to tumour cells.
Hosted by Professor Mark Rosenthal, Peter MacCallum Cancer Centre, Fiona discusses findings of her labs recently completed Phase IB safety trials.